tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tim Lugo, 22 are a BUY (68.75%), 10 are a HOLD (31.25%).
Analyst Tim Lugo, carries an average stock price target met ratio of 68.52% that have a potential upside of 49.16% achieved within 829 days. Previously, Tim Lugo worked at WILLIAM BLAIR.
Tim Lugo’s has documented 56 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 29-Oct-2024.
Analyst best performing recommendations are on EGRX (EAGLE PHARMACEUTICALS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 3/20/2013. The price target of $52 was fulfilled within 198 days with a profit of $19.23 (58.68%) receiving and performance score of 2.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$50
$27.19 (119.20%)
$50
1 months 5 days ago
(21-Sep-2025)
0/10 (0%)
$31.35 (168.10%)
Buy
$22
$-0.81 (-3.55%)
$98
1 months 12 days ago
(14-Sep-2025)
16/25 (64%)
$4.53 (25.93%)
229
Hold
$15
$-7.81 (-34.24%)
$160
1 months 18 days ago
(08-Sep-2025)
15/20 (75%)
$-2.64 (-14.97%)
133
Sell
$5
$-17.81 (-78.08%)
$40
2 months 2 days ago
(24-Aug-2025)
8/11 (72.73%)
$-13.06 (-72.31%)
55
Sell
$16
$-6.81 (-29.86%)
$10
2 months 6 days ago
(20-Aug-2025)
4/16 (25%)
$-4.06 (-20.24%)
246
What Year was the first public recommendation made by Tim Lugo?
